The Worldwide Market Landscape for Exosomes: Research and Translational Opportunities
Conference Recording Sep 17, 2013
About the Speaker
Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world. Dr. Razvi can be reached at: firstname.lastname@example.org
SELECTBIO has been tracking the qualitative and quantitative trends and opportunities in the exosomes and microvesicles marketplace. In this presentation, I provide an up-to-date snapshot of this evolving marketplace excerpted from SELECTBIO's various market reports on this topic. Presented are technologies for exosome analysis, segmentation of the exosome research market, market penetrance of various approaches for exosome study, disciplines/disease areas where exosome research is currently being carried out, and sizes of some of the market segments in this space—both from a basic research and a translational standpoint.